Immunic AG | WebDisclosure

PRESS RELEASE

published on 03/31/2026 at 12:30, 6 months 10 days ago

Immunic Strengthens Its Board of Directors with the Appointment of Seasoned Biopharmaceutical Executive Jon Congleton
Immunic strengthens its Board of Directors with the appointment of seasoned biopharmaceutical executive Jon Congleton on March 31, 2026, to support the development of novel oral therapies for neurologic diseases

Board Of Directors Biopharmaceutical Immunic Neurologic Diseases Jon Congleton
BRIEF

published on 03/10/2026 at 11:35, 7 months ago

Immunic obtient un brevet européen pour le dosage du Vidofludimus Calcium

Propriété Intellectuelle Sclérose En Plaques Vidofludimus Calcium Immunitaire Brevet Européen
BRIEF

published on 03/10/2026 at 11:35, 7 months ago

Immunic Secures European Patent for Vidofludimus Calcium Dosing

Intellectual Property Multiple Sclerosis Immunic Vidofludimus Calcium European Patent
PRESS RELEASE

published on 03/10/2026 at 11:30, 7 months ago

Immunic Announces Grant of Key European Patent Protecting Relevant Dosing Regimens for Vidofludimus Calcium
Immunic AG announces grant of key European patent protecting relevant dosing regimens for vidofludimus calcium, strengthening global intellectual property strategy

Intellectual Property Vidofludimus Calcium Immunic AG European Patent Dosing Regimens
BRIEF

published on 03/03/2026 at 12:35, 7 months 7 days ago

Immunisé pour participer à des conférences clés pour les investisseurs en mars

Biotechnologie Conférences D'investisseurs Immunitaire Maladies Neurologiques Troubles Gastro-intestinaux
BRIEF

published on 03/03/2026 at 12:35, 7 months 7 days ago

Immunic to Attend Key Investor Conferences in March

Biotechnology Investor Conferences Immunic Gastrointestinal Disorders Neurologic Diseases
PRESS RELEASE

published on 03/03/2026 at 12:30, 7 months 7 days ago

Immunic to Participate in Investor Conferences in March
Immunic, Inc. (Nasdaq: IMUX) to participate in investor conferences in March, including Leerink Partners Global Healthcare Conference and Stifel 2026 Virtual CNS Forum. Leading late-stage biotechnology company developing novel oral therapies

Biotechnology Investor Conferences Clinical Trials Immunic Inc. Oral Therapies
BRIEF

published on 02/26/2026 at 12:35, 7 months 12 days ago

Immunic, Inc. dévoile ses résultats financiers et ses plans stratégiques pour 2025

Sclérose En Plaques Vidofludimus Calcium Essais De Phase 3 Immunic Financials Investissement Privé
BRIEF

published on 02/26/2026 at 12:35, 7 months 12 days ago

Immunic, Inc. Reveals 2025 Financial Outcomes and Strategic Plans

Multiple Sclerosis Vidofludimus Calcium Phase 3 Trials Immunic Financials Private Investment
PRESS RELEASE

published on 02/26/2026 at 12:30, 7 months 12 days ago

Immunic, Inc. Reports Year-End 2025 Financial Results and Provides Corporate Update
Immunic, Inc. reports year-end 2025 financial results, announces completion of private placement, and plans for MS programs advancement and commercial transition

Private Placement Immunic Inc. Multiple Sclerosis Year-end Results Commercial Transition

Published on 10/10/2026 at 04:45, 13 hours 1 minute ago

Immutable Holdings and Jorge Masvidal's Gamebred Fighting Championship (FC) Enter Into Definitive Agreement for Proposed Reverse Takeover Transaction and Listing on the TSXV
Published on 10/10/2026 at 02:03, 15 hours 43 minutes ago

BrandPilot AI Announces Closing of Previously Announced Debt Settlement
Published on 10/10/2026 at 02:00, 15 hours 46 minutes ago

Battery X Metals Reports Estimated Driving Range Increase of Approximately 101 Kilometers Following a Single-Electric-Vehicle Performance Evaluation of Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Technology
Published on 10/09/2026 at 23:00, 18 hours 46 minutes ago

Trans Canada Gold Closes First Tranche of Non-Brokered Private Placement for Gross Proceeds of CDN $2,144,720
Published on 10/09/2026 at 22:15, 19 hours 31 minutes ago

Loop Industries to Host Second Quarter Fiscal 2027 Earnings Conference Call

View all ACCESSWIRE

Published on 10/10/2026 at 16:35, 1 hour 10 minutes ago

New Opportunities for Global Cooperation: Kexing Biopharm Shines at CPHI Milan 2026
Published on 10/10/2026 at 16:30, 1 hour 15 minutes ago

ZPMC-Built Infrastructure Supports China's First Offshore Wind Project to Deploy 18 MW Turbines at Scale
Published on 10/10/2026 at 10:05, 7 hours 40 minutes ago

ONLYOFFICE 10.0 brings AI tools, modular apps, and stronger security to its open-source office suite
Published on 10/09/2026 at 21:24, 20 hours 21 minutes ago

Branicks Group AG: Extraordinary General Meeting does not approve all items on the agenda
Published on 10/09/2026 at 21:17, 20 hours 28 minutes ago

EQS-Adhoc: Branicks Group AG: Agenda topic four at extraordinary general meeting rejected

View all EQS

Published on 10/09/2026 at 19:27, 22 hours 18 minutes ago

Disclosure of transactions in own shares from October 1 to October 9, 2026
Published on 10/09/2026 at 19:27, 22 hours 18 minutes ago

Déclaration hebdomadaire d'opérations effectuées du 1er au 9 octobre 2026
Published on 10/09/2026 at 18:01, 23 hours 45 minutes ago

Titre de mon communiqué
Published on 10/09/2026 at 18:01, 23 hours 45 minutes ago

Title of my press release
Published on 10/09/2026 at 17:45, 1 day ago

Déclaration des droits de vote à fin septembre 2026

View all LES ECHOS COMFI WIRE

News